Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

iHuman (IH) Shares Outstanding (Diluted Average) (2020 - 2024)

Historic Shares Outstanding (Diluted Average) for iHuman (IH) over the last 5 years, with Q4 2024 value amounting to $37.8 million.

  • iHuman's Shares Outstanding (Diluted Average) fell 70.33% to $37.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $37.8 million, marking a year-over-year decrease of 70.33%. This contributed to the annual value of $37.8 million for FY2024, which is 253.83% down from last year.
  • iHuman's Shares Outstanding (Diluted Average) amounted to $37.8 million in Q4 2024, which was down 70.33% from $38.0 million recorded in Q4 2023.
  • Over the past 5 years, iHuman's Shares Outstanding (Diluted Average) peaked at $41.7 million during Q4 2021, and registered a low of $34.2 million during Q4 2020.
  • For the 5-year period, iHuman's Shares Outstanding (Diluted Average) averaged around $37.9 million, with its median value being $38.0 million (2022).
  • In the last 5 years, iHuman's Shares Outstanding (Diluted Average) skyrocketed by 2210.83% in 2021 and then tumbled by 890.07% in 2022.
  • iHuman's Shares Outstanding (Diluted Average) (Quarter) stood at $34.2 million in 2020, then rose by 22.11% to $41.7 million in 2021, then fell by 8.9% to $38.0 million in 2022, then grew by 0.08% to $38.0 million in 2023, then decreased by 0.7% to $37.8 million in 2024.
  • Its Shares Outstanding (Diluted Average) stands at $37.8 million for Q4 2024, versus $38.0 million for Q4 2023 and $38.0 million for Q4 2022.